Anti-HER3 antibodies and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10196456
APP PUB NO 20170174784A1
SERIAL NO

15436267

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ROCHE GLYCART AG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bossenmaier, Birgit Seefeld, DE 44 536
Dimoudis, Nikolaos Wielenbach, DE 20 336
Friess, Thomas Diessen-Dettenhofen, DE 55 437
Georges, Guy Habach, DE 127 966
Kolm, Irene Penzberg, DE 7 38
Krell, Hans-Willi Penzberg, DE 37 210
Lifke, Valeria Penzberg, DE 35 255
Moessner, Ekkehard Kreuzlingen, CH 194 2920

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 5, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 5, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00